Click Here for 5% Off Your First Aladdin Purchase!

Name And Identifier

ID: ALA1766974

Max Phase: Preclinical

Molecular Formula: C11H10ClF2NO2

Molecular Weight: 261.65

Molecule Type: Small molecule

Representations

Molfile:

Canonical SMILES:

copy

Standard InChI:

copy

Standard InChI Key:

copy

Alternative Forms

  1. Parent:

    ALA1766974

    ---

Molecule Features

Natural Product: NoChemical Probe: No
Molecule Type: Small moleculeFirst In Class: No
Chirality: NoProdrug: No
Oral: NoParenteral: No
Topical: NoBlack Box: No
Availability: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for Indication

Mechanisms of Action

Mechanism of ActionAction TypeTarget NameTarget TypeTarget OrganismBinding Site Name

Activity Summary

Bioactivity SummaryCount
Ratio EC501
EC502
Assay SummaryCount
B-Binding1
F-Functional2

Properties

Molecular Weight: 261.65Molecular Weight (Monoisotopic): 261.0368
AlogP: 2.11#Rotatable Bonds: 1
Polar Surface Area: 40.54Molecular Species: NEUTRAL
HBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3
HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.41CX Basic pKa:
CX LogP: 2.22CX LogD: 2.21
Aromatic Rings: 1Heavy Atoms: 17
QED Weighted: 0.79Np Likeness Score: -0.54

References

1. Möcklinghoff S, van Otterlo WA, Rose R, Fuchs S, Zimmermann TJ, Dominguez Seoane M, Waldmann H, Ottmann C, Brunsveld L..  (2011)  Design and evaluation of fragment-like estrogen receptor tetrahydroisoquinoline ligands from a scaffold-detection approach.,  54  (7):   [PMID:21381753]

Source

Source(1):

  • Scientific Literature